Epigral Limited to Establish New Manufacturing Facilities in Gujarat for Epoxy Resin and MPP
Epigral Limited has announced a significant expansion initiative, planning to establish new manufacturing facilities at its existing location in Dahej, Gujarat. The company is set to introduce production capabilities for both Epoxy Resin & Formulations and Multi-Purpose Plant (MPP) as part of its strategic growth goals.The capital expenditure involves expanding the product portfolio across these lines. For Epoxy Resin & Formulations, Epigral has outlined a capacity target of 125,000 TPA. The proposed capacity for both products is scheduled to be added by H2 FY2028.
Details regarding this large-scale expansion, including investment requirements and financing structure, are as follows:
| Particulars | Epoxy Resin & Formulations | Multi-Purpose Plant (MPP) |
|---|---|---|
| Proposed Capacity | 125,000 TPA | N/A |
| Investment Required | Estimated Rs. 600 Cr. | Estimated Rs. 600 Cr. |
| Mode of Financing | Mix of Debt and Internal Accruals | Mix of Debt and Internal Accruals |
| Completion Timeline | By H2 FY2028 | By H2 FY2028 |
The rationale behind this investment is to expand the product portfolio, allowing Epigral Limited to meet market demands across both new facilities. The planned capital expenditure underscores the company's commitment to strategic growth and operational enhancement in Gujarat.
EPIGRAL Stock Price Movement
Shares of Epigral Limited are edging higher to ₹1178.8 as of 2:26 PM today, gaining 1.38% in live trading. The stock sees solid market interest, with over 460,736 shares traded so far during the session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.